|
.
See Category: Diseases of the skin and subcutaneous tissue
ICD-10 (CM) Code and Descriptor
L85.8 |
Other specified epidermal thickening
|
L858 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
32.11%
|
23.96%
|
14.16%
|
8.43%
|
6.37%
|
4.28%
|
3.23%
|
2.01%
|
1.55%
|
1.18%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for L85.8*:
CPT |
Description |
Number of Claims |
Sum Performed |
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,813
|
2,095
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,377
|
1,380
|
99213
|
OFFICE O/P EST LOW 20 MIN |
639
|
639
|
17110
|
DESTRUCT B9 LESION 1-14 |
454
|
454
|
11102
|
TANGNTL BX SKIN SINGLE LES |
332
|
332
|
G0467
|
FQHC VISIT, ESTAB PT |
294
|
294
|
17000
|
DESTRUCT PREMALG LESION |
291
|
291
|
99212
|
OFFICE O/P EST SF 10 MIN |
242
|
242
|
99214
|
OFFICE O/P EST MOD 30 MIN |
204
|
204
|
17003
|
DESTRUCT PREMALG LES 2-14 |
147
|
369
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
121
|
121
|
11104
|
PUNCH BX SKIN SINGLE LESION |
103
|
103
|
88312
|
SPECIAL STAINS GROUP 1 |
80
|
109
|
96405
|
CHEMO INTRALESIONAL UP TO 7 |
79
|
79
|
J2704
|
INJ, PROPOFOL, 10 MG |
78
|
1,755
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
75
|
75
|
80053
|
COMPREHEN METABOLIC PANEL |
69
|
69
|
J9190
|
FLUOROURACIL INJECTION |
67
|
76
|
11900
|
INJECT SKIN LESIONS |
65
|
65
|
J3010
|
FENTANYL CITRATE INJECTION |
63
|
77
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
L85.8 related to the following DRG Codes:
606-607
|